Regulatory Oversight, Food and Drug Administration (FDA), Healthcare Reform

Can Food Really Be Medicine? Transforming Health Care One Bite at a Time – Diagnosing Health Care Video Podcast

Epstein Becker & Green on 7/31/2025

Can food really be the prescription for better health? Discover how the “Food as Medicine” movement is reshaping health care and what it means for patients, providers, and the future of wellness. On this episode, special...more

HHS Restructuring and Workforce Reductions – Key Implications for the Health Care Industry

Mintz - Health Care Viewpoints on 4/15/2025

As spring arrived in the mid-Atlantic region, the Department of Health and Human Services (HHS) under Robert F. Kennedy, Jr. followed through with a previously announced Reduction in Force (RIF) that reduced the department’s...more

Recent Healthcare-Related Artificial Intelligence Developments

Sheppard Mullin Richter & Hampton LLP on 2/27/2024

AI is here to stay. The development and use of artificial intelligence (“AI”) is rapidly growing in the healthcare landscape with no signs of slowing down. From a governmental perspective, many federal agencies are embracing...more

STeP’ing up: FDA advances expedited device review program, set to begin in March

Hogan Lovells on 1/13/2021

On January 6, 2021, the U.S. Food and Drug Administration (FDA) published a final guidance outlining the Safer Technologies Program (STeP) for Medical Devices: a voluntary program for medical devices and device-led...more

Will FDA be forced to implement a drug importation program?

Hogan Lovells on 7/23/2019

Over a year ago, HHS Secretary Alex Azar requested that FDA establish a working group to explore how drug importation “could help address price hikes and supply disruptions.” The FDA working group was not assigned the task of...more

FDA proposes new ways for prescription drugs to become available over-the-counter

Hogan Lovells on 7/20/2018

On Tuesday, FDA’s Center for Drug Evaluation and Research (CDER) announced a draft guidance titled “Innovative Approaches for Nonprescription Drug Products” that could aid drug manufacturers who want to sell, without a...more

Regulatory Oversight › Food and Drug Administration (FDA) › Healthcare Reform